Skip Navigation

JNCI Journal of the National Cancer Institute 2007 99(14):1057; doi:10.1093/jnci/djm077
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Japanese Translation
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2007.

IN THIS ISSUE

The first 10% of the full text of this article appears below.

Health Claims of Tomatoes, Lycopene, and Cancer

Health claims that describe the relationship between a food or food component and a disease—such as those based on reports of an association between tomato and/or lycopene intake and decreased risk of some types of cancer—require premarket approval by the U.S. Food and Drug Administration (FDA) to be included on labels of conventional foods and dietary supplements. Kavanaugh et al. (p. 1074) describe the FDA's evidence-based review of the scientific data on the relationship between tomato and/or lycopene intake and the . . . [Full Text of this Article]

Kaposi Sarcoma, Herpesvirus, and Immunosuppression

Microbubbles, Chemotherapy Delivery, and Tumor Imaging

HDAC1 Expression and Inhibition in Drug-Resistant Neuroblastoma

Plasma Vitamin D Concentration and Risk of Colorectal Cancer


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

The U.S. Food and Drug Administration's Evidence-Based Review for Qualified Health Claims: Tomatoes, Lycopene, and Cancer
Claudine J. Kavanaugh, Paula R. Trumbo, and Kathleen C. Ellwood
J Natl Cancer Inst 2007 99: 1074-1085. [Abstract] [Full Text] [PDF]

A Nested Case–Control Study of Plasma 25-Hydroxyvitamin D Concentrations and Risk of Colorectal Cancer
Kana Wu, Diane Feskanich, Charles S. Fuchs, Walter C. Willett, Bruce W. Hollis, and Edward L. Giovannucci
J Natl Cancer Inst 2007 99: 1120-1129. [Abstract] [Full Text] [PDF]

Multifunctional Nanoparticles for Combining Ultrasonic Tumor Imaging and Targeted Chemotherapy
Natalya Rapoport, Zhonggao Gao, and Anne Kennedy
J Natl Cancer Inst 2007 99: 1095-1106. [Abstract] [Full Text] [PDF]

Histone Deacetylase 1 Gene Expression and Sensitization of Multidrug-Resistant Neuroblastoma Cell Lines to Cytotoxic Agents by Depsipeptide
Nino Keshelava, Elai Davicioni, Zesheng Wan, Lingyun Ji, Richard Sposto, Timothy J. Triche, and C. Patrick Reynolds
J Natl Cancer Inst 2007 99: 1107-1119. [Abstract] [Full Text] [PDF]

Evidence for a Multiclonal Origin of Multicentric Advanced Lesions of Kaposi Sarcoma
Renan Duprez, Vincent Lacoste, Josette Brière, Pierre Couppié, Camille Frances, Dominique Sainte-Marie, Eric Kassa-Kelembho, Marie-Jeanne Lando, Jean-Louis Essame Oyono, Blaise Nkegoum, Oumkaltoum Hbid, Antoine Mahé, Céleste Lebbé, Patricia Tortevoye, Michel Huerre, and Antoine Gessain
J Natl Cancer Inst 2007 99: 1086-1094. [Abstract] [Full Text] [PDF]

Does Prostate-Specific Antigen Screening Influence the Results of Studies of Tomatoes, Lycopene, and Prostate Cancer Risk?
Edward Giovannucci
J Natl Cancer Inst 2007 99: 1060-1062. [Extract] [Full Text] [PDF]

Evidence-Based Reviews in Support of Health Policy Decisions
Paul M. Coates
J Natl Cancer Inst 2007 99: 1059. [Extract] [Full Text] [PDF]

The Origin of Kaposi Sarcoma
Parkash S. Gill
J Natl Cancer Inst 2007 99: 1063. [Extract] [Full Text] [PDF]